Naimi Sabrine, Viennois Emilie, Gewirtz Andrew T, Chassaing Benoit
INSERM U1016, team "Mucosal microbiota in chronic inflammatory diseases", CNRS UMR 8104, Université de Paris, Paris, France.
INSERM, U1149, Center of Research on Inflammation, Université de Paris, Paris, France.
Microbiome. 2021 Mar 22;9(1):66. doi: 10.1186/s40168-020-00996-6.
Epidemiologic evidence and animal studies implicate dietary emulsifiers in contributing to the increased prevalence of diseases associated with intestinal inflammation, including inflammatory bowel diseases and metabolic syndrome. Two synthetic emulsifiers in particular, carboxymethylcellulose and polysorbate 80, profoundly impact intestinal microbiota in a manner that promotes gut inflammation and associated disease states. In contrast, the extent to which other food additives with emulsifying properties might impact intestinal microbiota composition and function is not yet known.
To help fill this knowledge gap, we examined here the extent to which a human microbiota, maintained ex vivo in the MiniBioReactor Array model, was impacted by 20 different commonly used dietary emulsifiers. Microbiota density, composition, gene expression, and pro-inflammatory potential (bioactive lipopolysaccharide and flagellin) were measured daily.
In accordance with previous studies, both carboxymethylcellulose and polysorbate 80 induced a lasting seemingly detrimental impact on microbiota composition and function. While many of the other 18 additives tested had impacts of similar extent, some, such as lecithin, did not significantly impact microbiota in this model. Particularly stark detrimental impacts were observed in response to various carrageenans and gums, which altered microbiota density, composition, and expression of pro-inflammatory molecules.
These results indicate that numerous, but not all, commonly used emulsifiers can directly alter gut microbiota in a manner expected to promote intestinal inflammation. Moreover, these data suggest that clinical trials are needed to reduce the usage of the most detrimental compounds in favor of the use of emulsifying agents with no or low impact on the microbiota. Video abstract.
流行病学证据和动物研究表明,膳食乳化剂与肠道炎症相关疾病(包括炎症性肠病和代谢综合征)患病率的增加有关。特别是两种合成乳化剂,羧甲基纤维素和聚山梨醇酯80,会以促进肠道炎症和相关疾病状态的方式深刻影响肠道微生物群。相比之下,其他具有乳化特性的食品添加剂对肠道微生物群组成和功能的影响程度尚不清楚。
为了填补这一知识空白,我们在此研究了在MiniBioReactor Array模型中离体维持的人类微生物群受20种不同常用膳食乳化剂影响的程度。每天测量微生物群密度、组成、基因表达和促炎潜力(生物活性脂多糖和鞭毛蛋白)。
与先前的研究一致,羧甲基纤维素和聚山梨醇酯80均对微生物群组成和功能产生了持久的看似有害的影响。虽然测试的其他18种添加剂中有许多产生了类似程度的影响,但有些添加剂,如卵磷脂,在该模型中对微生物群没有显著影响。在对各种角叉菜胶和树胶的反应中观察到特别明显的有害影响,它们改变了微生物群密度、组成和促炎分子的表达。
这些结果表明,许多但并非所有常用的乳化剂都可以直接改变肠道微生物群,其方式预计会促进肠道炎症。此外,这些数据表明需要进行临床试验,以减少最有害化合物的使用,转而使用对微生物群没有影响或影响较小的乳化剂。视频摘要。